CASP3 and amyotrophic lateral sclerosis: Additionally, SB202190 enhanced the ALS-induced conversion of LC3-I to LC3-II resulting in an increase in the levels of cleaved caspase-3 and PARP in both A375 and skmel-5 cells (Figure 3E and 3F).